Mirador Capital Partners LP Pacific Biosciences Of California, Inc. Transaction History
Mirador Capital Partners LP
- $597 Million
- Q2 2025
A detailed history of Mirador Capital Partners LP transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Mirador Capital Partners LP holds 563,670 shares of PACB stock, worth $834,231. This represents 0.12% of its overall portfolio holdings.
Number of Shares
563,670
Previous 515,734
9.29%
Holding current value
$834,231
Previous $587,000
18.91%
% of portfolio
0.12%
Previous 0.11%
Shares
11 transactions
Others Institutions Holding PACB
# of Institutions
259Shares Held
227MCall Options Held
2.15MPut Options Held
967K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl36.5MShares$54 Million0.46% of portfolio
-
Black Rock Inc. New York, NY23.6MShares$34.9 Million0.0% of portfolio
-
Madrone Advisors, LLC Menlo Park, CA23.4MShares$34.6 Million4.62% of portfolio
-
Edmond De Rothschild Holding S.A. Chambesy, V821.9MShares$32.3 Million0.46% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M020.5MShares$30.3 Million0.08% of portfolio
About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- Ticker PACB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 224,840,992
- Market Cap $333M
- Description
- Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...